Search

Your search keyword '"Toshikazu Takeda"' showing total 40 results
Start Over Author "Toshikazu Takeda" Publisher ovid technologies (wolters kluwer health)
40 results on '"Toshikazu Takeda"'

3. MP16-01 OVERCOMING CABAZITAXEL RESISTANCE BY G2/M REGULATING GENES IN CASTRATION-RESISTANT PROSTATE CANCER

Author

Hiroshi Hongo, Mototsugu Oya, Takeo Kosaka, Toshikazu Takeda, Yota Yasumizu, Kazuhiro Matsumoto, Yoshinori Yanai, Ryuichi Mizuno, and Nobuyuki Tanaka

Subjects
Extremely Poor, Prostate cancer, Cabazitaxel, business.industry, Urology, Cancer research, medicine, Castration resistant, urologic and male genital diseases, medicine.disease, business, Gene, medicine.drug
Abstract

INTRODUCTION AND OBJECTIVE:Because CBZ-resistant CRPC has an extremely poor prognosis, establishment of a novel treatment for CBZ-resistant CRPC is greatly needed. The aim of this study was to expl...

Published
2020
Full Text
View/download PDF

4. MP72-13 PERFORMING TRANSURETHRAL RESECTION UNDER GENERAL ANESTHESIA MAY CONTRIBUTE TO HIGHER RECURRENCE RATES IN HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER

Author

Yuto Baba, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Keisuke Shigeta, Ryuichi Mizuno, Nobuyuki Tanaka, Eiji Kikuchi, Shinya Morita, Yota Yasumizu, and Mototsugu Oya

Subjects
medicine.medical_specialty, Bladder cancer, business.industry, Urology, medicine, Non muscle invasive, medicine.disease, business, Resection, Surgery
Published
2020
Full Text
View/download PDF

5. MP19-03 EXTERNAL VALIDATION OF THE 'OPTIMAL PSA FOLLOW-UP SCHEDULE AFTER RADICAL PROSTATECTOMY' IN A NEW COHORT

Author

Ryuichi Mizuno, Shinya Morita, Toshiaki Shinojima, Nobuyuki Tanaka, Mototsugu Oya, Hiroshi Asanuma, Kazuhiro Matsumoto, Yoshinori Yanai, Takeo Kosaka, and Toshikazu Takeda

Subjects
Biochemical recurrence, Oncology, medicine.medical_specialty, Schedule, Prostatectomy, business.industry, Urology, medicine.medical_treatment, External validation, urologic and male genital diseases, Asymptomatic, Prostate-specific antigen, Internal medicine, Cohort, medicine, medicine.symptom, business
Abstract

INTRODUCTION AND OBJECTIVE:Biochemical recurrence (BCR) after radical prostatectomy (RP) is most commonly diagnosed by detecting an asymptomatic prostate specific antigen (PSA) increase. PSA monito...

Published
2020
Full Text
View/download PDF

6. MP16-04 IN SILICO SCREENING FOR IDENTIFICATION OF NOVEL DRUGS FOR OVERCOMING CABAZITAXEL-RESISTANT PROSTATE CANCER

Author

Takeo Kosaka, Toshikazu Takeda, Hiroshi Hongo, Nobuyuki Tanaka, Mototsugu Oya, Ryuichi Mizuno, Kazuhiro Matsumoto, and Yota Yasumizu

Subjects
Prostate cancer, Cabazitaxel, business.industry, Urology, In silico, medicine, Cancer research, Identification (biology), medicine.disease, business, medicine.drug
Abstract

INTRODUCTION AND OBJECTIVE:Cabazitaxel (CBZ) has been identified as the most effective cytotoxic agent for improving survival in men with docetaxel-refractory castration-resistant prostate cancer (...

Published
2020
Full Text
View/download PDF

7. MP08-19 A SIMPLE/RAPID RNA IMAGING TECHNIQUE QHCR REVEALS MALIGNANCY ASSOCIATED WITH LONG NON-CODING RNA IN CLEAR CELL RENAL CELL CARCINOMA

Author

Hiroshi Asanuma, Kazuhiro Matsumoto, Shinya Morita, Youta Yasumizu, Mototsugu Oya, Ryuichi Mizuno, Ryohei Kufukihara, Nobuyuki Tanaka, Takeo Kosaka, and Toshikazu Takeda

Subjects
Clear cell renal cell carcinoma, business.industry, Urology, medicine, Cancer research, RNA, Imaging technique, medicine.disease, Malignancy, business, Long non-coding RNA
Abstract

INTRODUCTIONAND OBJECTIVE: The relationship between malignant neoplasms and long non-coding RNA (lncRNA) have been emerging. Yet, little is known about cancerous lncRNA profiles due to lack of appr...

Published
2020
Full Text
View/download PDF

8. MP01-01 TNFAIP2: A POTENTIAL TARGET IN PLATINUM RESISTANCE UROTHELIAL CARCINOMA

Author

Nobuyuki Tanaka, Hiroshi Asanuma, Kimiharu Takamatsu, Eiji Kikuchi, Shinya Morita, Takeo Kosaka, Toshikazu Takeda, Shuji Mikami, Yota Yasumizu, Yasumasa Miyazaki, Mototsugu Oya, Kazuhiro Matsumoto, Naoya Niwa, Ryuichi Mizuno, and Hiroshi Hongo

Subjects
Cisplatin, Chemotherapy, Metastatic Urothelial Carcinoma, business.industry, Urology, medicine.medical_treatment, Locally advanced, Gold standard (test), Platinum resistance, medicine, Cancer research, business, medicine.drug, Urothelial carcinoma
Abstract

INTRODUCTION AND OBJECTIVE:Cisplatin (CDDP)-based chemotherapy is the gold standard treatment for patients with locally advanced or metastatic urothelial carcinoma (UC). However, the phenotypic hal...

Published
2020
Full Text
View/download PDF

9. PD43-06 IMPACT OF PROSTATIC SHAPE ON THE DIFFICULTY OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY

Author

Hiroshi Asanuma, Ken Kamisawa, Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Yota Yasumizu, Kimiharu Takamatsu, Shinya Morita, Kazuhiro Matsumoto, Nobuyuki Tanaka, and Ryuichi Mizuno

Subjects
medicine.medical_specialty, Prostate cancer, Laparoscopic radical prostatectomy, business.industry, Urology, medicine.medical_treatment, medicine, Treatment options, Robot assisted laparoscopic radical prostatectomy, medicine.disease, business
Abstract

INTRODUCTION AND OBJECTIVE:Robot-assisted laparoscopic radical prostatectomy (RALP) is a valuable treatment option for clinically localized prostate cancer . However, RALP for larger prostates is a...

Published
2020
Full Text
View/download PDF

10. PD64-03 UNCOVERING INTRA-TUMOR AXL EXPRESSION HETEROGENEITY AND OUTCOMES IN CLEAR CELL RENAL CELL CARCINOMA: COMPREHENSIVE ANALYSIS FOR PRIMARY AND METASTATIC LESION

Author

Yota Yasumizu, Hiroshi Asanuma, Kyohei Hakozaki, Nobuyuki Tanaka, Kimiharu Takamatsu, Takeo Kosaka, Toshikazu Takeda, Ryuichi Mizuno, Kazuhiro Matsumoto, Mototsugu Oya, Shinya Morita, and Shuji Mikami

Subjects
biology, Cabozantinib, business.industry, Urology, urologic and male genital diseases, medicine.disease, Receptor tyrosine kinase, Metastatic lesion, chemistry.chemical_compound, Clear cell renal cell carcinoma, chemistry, Renal cell carcinoma, biology.protein, medicine, Cancer research, business
Abstract

INTRODUCTION AND OBJECTIVE:AXL is the TAM family of receptor tyrosine kinases targeted by a new approved Cabozantinib in renal cell carcinoma (RCC). A growing body of evidence suggests a relationsh...

Published
2020
Full Text
View/download PDF

11. MP76-03 OPTIMAL TREATMENT STRATEGY FOR PARATESTICULAR LIPOSARCOMA

Author

Rei Kamitani, Kazuhiro Matsumoto, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Takeo Kosaka, Ryuichi Mizuno, Hiroshi Asanuma, and Mototsugu Oya Tokyo, Japan

Subjects
body regions, medicine.medical_specialty, business.industry, Urology, Soft tissue sarcoma, Optimal treatment, medicine, Radiology, Paratesticular region, Liposarcoma, medicine.disease, business
Abstract

INTRODUCTION AND OBJECTIVE:Liposarcoma is one of the most common subtypes of soft tissue sarcoma. The tumor often develops in the lower extremities and the retroperitoneal or paratesticular region....

Published
2020
Full Text
View/download PDF

12. MP01-02 SULFASALAZINE COULD MODULATE THE CD44V9-XCT SYSTEM AND ENHANCE CDDP-INDUCED CYTOTOXIC EFFECTS IN METASTATIC BLADDER CANCER; A NOVEL THERAPEUTIC STRATEGY FOR METASTATIC BLADDER CANCER

Author

Eiji Kikuchi, Kazuhiro Matsumoto, Hideyuki Saya, Toshikazu Takeda, Koichiro Ogihara, and Mototsugu Oya

Subjects
Metastatic bladder cancer, Cisplatin, Sulfasalazine, business.industry, Urology, medicine, Cancer research, Cytotoxic T cell, business, female genital diseases and pregnancy complications, medicine.drug, Therapeutic strategy
Abstract

INTRODUCTION AND OBJECTIVE:The development of a new therapeutic strategy against cisplatin (CDDP) resistant metastatic bladder cancer is strongly warranted. Recently, sulfasalazine (SSZ), widely us...

Published
2020
Full Text
View/download PDF

13. MP36-07 EVALUATING THE DIAGNOSTIC ACCURACY OF VESICAL IMAGING-REPORTING AND DATA SYSTEM FOR DETECTING MUSCLE-INVASIVE BLADDER CANCER IN REAL CLINICAL SETTING

Author

Keisuke Shigeta, Nobuyuki Tanaka, Eiji Kikuchi, Hirotaka Akita, Youta Yasumizu, Mototsugu Oya, Ryohei Kufukihara, Masahiro Jinzaki, Yuki Arita, Toshikazu Takeda, Kazuhiro Matsumoto, and Ryuichi Mizuno

Subjects
medicine.medical_specialty, Bladder cancer, Modality (human–computer interaction), genetic structures, business.industry, Urology, medicine, Muscle invasive, Diagnostic accuracy, Radiology, skin and connective tissue diseases, medicine.disease, business
Abstract

INTRODUCTION AND OBJECTIVE:Although Vesical Imaging-Reporting and Data System (VI-RADS) has introduced for additional diagnostic modality for bladder cancer (Bca) patients, the diagnostic accuracy ...

Published
2020
Full Text
View/download PDF

14. MP08-08 GENOMIC LANDSCAPE AND MOLECULAR CHARACTERIZATION OF RENAL CELL CARCINOMA IN DIALYSIS PATIENTS

Author

Takeo Kosaka, Toshikazu Takeda, Kazuhiro Kakimi, Shinya Morita, Takashi Kamatani, Mototsugu Oya, Ryohei Takahashi, Nobuyuki Tanaka, Shuji Mikami, Ryuichi Mizuno, Tatsuhiko Tsunoda, Kazuhiro Matsumoto, and Fuyuki Miya

Subjects
medicine.medical_specialty, animal structures, business.industry, Renal cell carcinoma, Urology, fungi, medicine, Chronic renal failure, Dialysis patients, business, medicine.disease
Abstract

INTRODUCTION AND OBJECTIVE:The number of chronic renal failure has been rapidly growing. Further, not only in advanced nations, the number of dialysis patients continues to increase explosively eve...

Published
2020
Full Text
View/download PDF

16. PD18-04 ARE SURVIVAL OUTCOMES AFTER NEOADJUVANT CHEMOTHERAPY SUPERIOR TO THOSE AFTER UPFRONT RADICAL NEPHROURETERECTOMY FOR NODE-POSITIVE UPPER TRACT UROTHELIAL CARCINOMA? RESULTS OF A MULTI-CENTER COHORT STUDY

Author

Eiji Kikuchi, Kazuhiro Matsumoto, Nobuyuki Tanaka, Takeo Kosaka, Toshikazu Takeda, Ryuichi Mizuno, Mototsugu Oya, Yota Yasumizu, Hiroshi Asanuma, Shinya Morita, and Keisuke Shigeta

Subjects
medicine.medical_specialty, Chemotherapy, Upper tract, business.industry, Urology, medicine.medical_treatment, Node (networking), medicine, Center (algebra and category theory), Radiology, business, Urothelial carcinoma, Cohort study
Published
2020
Full Text
View/download PDF

17. MP18-09 ROLE FOR THE ECTONUCLEOTIDASE CD39

Author

Tetsushi Murakami, Shinya Morita, Nobuyuki Tanaka, Kimiharu Takamatsu, Takeo Kosaka, Toshikazu Takeda, Kyohei Hakozaki, Youta Yasumizu, Hiroshi Asanmua, Kazuhiro Matsumoto, Mototsugu Oya, Shuji Mikami, and Ryuichi Mizuno

Subjects
biology, business.industry, Urology, Cancer immunity, medicine.disease, Adenosine, Clear cell renal cell carcinoma, PD-L1, medicine, biology.protein, Cancer research, Extracellular, Ectonucleotidase, business, medicine.drug
Abstract

INTRODUCTION AND OBJECTIVE:Extracellular adenosine generates a highly immunosuppressive microenvironment in solid tumors. The ectonucleotidases, CD39 and CD73, are important factors in adenosine pr...

Published
2020
Full Text
View/download PDF

18. MP41-14 TYPE OF PATIENTS IN WHOM BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY CAN BE OBSERVED WITHOUT SALVAGE THERAPY

Author

Eiji Kikuchi, Toshiaki Shinojima, Ryuichi Mizuno, Hiroshi Asanuma, Kazuhiro Matsumoto, Masayuki Hagiwara, Naoya Niwa, Satoshi Hara, Takeo Kosaka, Toshikazu Takeda, Nobuyuki Tanaka, Shinya Morita, and Mototsugu Oya

Subjects
Biochemical recurrence, medicine.medical_specialty, Prostatectomy, business.industry, Urology, medicine.medical_treatment, medicine, Salvage therapy, business
Published
2019
Full Text
View/download PDF

19. MP76-03 KIDNEY GRAFT DAMAGE AFTER LONG COLD ISCHEMIA TIME IS ATTENUATED BY RECOMBINANT THROMBOMODULIN ALPHA IN A RAT KIDNEY TRANSPLANT MODEL

Author

Mototsugu Oya, Masayuki Shimoda, Hiroshi Asanuma, Takeo Kosaka, Toshikazu Takeda, Kazunobu Shinoda, Shinya Morita, Soutaro Kitaoka, Ryuichi Mizuno, Ryohei Takahashi, Toshiaki Shinojima, Satoshi Tamaki, Kazuhiro Matsumoto, Nobuyuki Tanaka, and Eiji Kikuchi

Subjects
medicine.medical_specialty, Kidney, business.industry, Urology, Rat kidney, Alpha (ethology), Thrombomodulin, Cold Ischemia Time, law.invention, Endocrinology, medicine.anatomical_structure, law, Internal medicine, Recombinant DNA, medicine, business
Published
2019
Full Text
View/download PDF

20. MP50-06 COULD LAPAROSCOPIC SURGERY HAVE SAME LONG-TERM ONCOLOGICAL OUTCOMES AS OPEN RADICAL NEPHROURETERECTOMY IN T3N0M0 UPPER TRACT UROTHELIAL CARCINOMA? A MULTICENTER COHORT STUDY ADJUSTED BY PROPENSITY SCORE MATCHING

Author

Ryuichi Mizuno, Takayuki Abe, Masayuki Hagiwara, Mototsugu Oya, Keisuke Shigeta, Masahiro Jinzaki, Kazuhiro Matsumoto, Eiji Kikuchi, Toshikazu Takeda, and Koichiro Ogihara

Subjects
Laparoscopic surgery, medicine.medical_specialty, Upper tract, business.industry, Urology, medicine.medical_treatment, Propensity score matching, Locally advanced, Medicine, business, Urothelial carcinoma, Cohort study, Surgery
Abstract

INTRODUCTION AND OBJECTIVES:The clinical indication of laparoscopic radical nephroureterectomy (LRNU) for locally advanced upper tract urothelial carcinoma (UTUC) patients remain controversial. Our...

Published
2019
Full Text
View/download PDF

21. MP69-06 RISK FACTORS FOR HEMODYNAMIC INSTABILITY DURING LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA

Author

Eiji Kikuchi, Yu Teranishi, Nobuyuki Tanaka, Toshiaki Shinojima, Hiroshi Asanuma, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Kimiharu Takamatsu, Shinya Morita, Kyohei Hakozaki, and Ryuichi Mizuno

Subjects
Surgical resection, medicine.medical_specialty, endocrine system diseases, genetic structures, Laparoscopic adrenalectomy, business.industry, Urology, education, medicine.disease, Surgery, Pheochromocytoma, Medicine, business, Hemodynamic instability
Abstract

INTRODUCTION AND OBJECTIVES:Pheochromocytoma is a rare neuroendocrine tumor that secretes catecholamines and mainly originates in the adrenal grand. Surgical resection is the only curative therapy ...

Published
2019
Full Text
View/download PDF

22. PD31-02 WHAT TIMING IS APPROPRIATE FOR A BIOCHEMICAL EVALUATION AFTER LAPAROSCOPIC ADRENALECTOMY FOR UNILATERAL ALDOSTERONE-PRODUCING ADENOMA?

Author

Hiroshi Asanuma, Shinya Morita, Ryuichi Mizuno, Isao Kurihara, Yota Yasumizu, Takeo Kosaka, Toshikazu Takeda, Nobuyuki Tanaka, Mototsugu Oya, Hiroshi Itoh, Kimiharu Takamatsu, and Kazuhiro Matsumoto

Subjects
medicine.medical_specialty, Laparoscopic adrenalectomy, business.industry, Urology, Aldosterone producing adenoma, medicine, business
Published
2020
Full Text
View/download PDF

23. MP18-05 NOVEL PROGNOSTIFICATION MODEL FOR CLEAR CELL RENAL CELL CARCINOMA

Author

Kimiharu Takamatsu, Shinya Morita, Yota Yasumizu, Takeo Kosaka, Toshikazu Takeda, Ryuichi Mizuno, Nobuyuki Tanaka, Mototsugu Oya, Kyohei Hakozaki, Hiroshi Asanuma, Kazuhiro Matsumoto, Ryohei Takahashi, and Shuji Mikami

Subjects
Clear cell renal cell carcinoma, Immune system, Standard of care, business.industry, Renal cell carcinoma, Urology, Cancer research, Medicine, urologic and male genital diseases, business, Cluster analysis, medicine.disease, Immune checkpoint
Abstract

INTRODUCTION AND OBJECTIVE:Immuno-oncology (IO) treatment has become the standard of care for locally-advanced and/or metastatic renal cell carcinoma (RCC). Yet, we do not fully understand whole pi...

Published
2020
Full Text
View/download PDF

24. MP13-04 DO ALL CASES OF MAGNETIC RESONANCE IMAGING NEGATIVE HAVE GOOD PROGNOSIS?

Author

Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Ryuichi Mizuno, Yota Yasumizu, Yoshinori Yanai, Nobuyuki Tanaka, and Hiroshi Hongo

Subjects
medicine.medical_specialty, medicine.diagnostic_test, business.industry, Urology, Magnetic resonance imaging, equipment and supplies, medicine.disease, Prostate cancer, medicine, Radiology, Good prognosis, business, human activities, Multiparametric Magnetic Resonance Imaging
Abstract

INTRODUCTION AND OBJECTIVE:Multiparametric magnetic resonance imaging (mpMRI) has been increasingly used these days and has a role in detecting clinically significant prostate cancer in men with el...

Published
2020
Full Text
View/download PDF

28. PD47-10 MRI TUMOR CONTACT LENGTH AS A PREDICTOR OF EXTRACAPSULAR EXTENSION: OPTIMAL THRESHOLD FOR ANTERIOR AND POSTERIOR PROSTATE CANCER

Author

Kimiharu Takamatsu, Kazuhiro Matsumoto, Ryuichi Mizuno, Hiroshi Asanuma, Eiji Kikuchi, Mototsugu Oya, Takeo Kosaka, Toshikazu Takeda, and Seiya Hattori

Subjects
Prostate cancer, medicine.medical_specialty, business.industry, Urology, medicine, Extension (predicate logic), Radiology, medicine.disease, business
Published
2018
Full Text
View/download PDF

29. MP05-20 IMPACT OF TUMOR LOCATION ON BIOCHEMICAL RECURRENCE AFTER LAPAROSCOPIC RADICAL PROSTATECTOMY

Author

Shinya Morita, Toshiaki Shinojima, Kimiharu Takamatsu, Ryuichi Mizuno, Takeo Kosaka, Toshikazu Takeda, Mototsugu Oya, Kazuhiro Matsumoto, Eiji Kikuchi, and Hiroshi Asanuma

Subjects
Biochemical recurrence, medicine.medical_specialty, Laparoscopic radical prostatectomy, business.industry, Urology, medicine.medical_treatment, medicine, Tumor location, business
Published
2018
Full Text
View/download PDF

30. MP97-17 A COMPARISON OF INTRAPERITONEAL ONLAY MESH REPAIR VS. MINIMALLY INVASIVE SUTURE REPAIR OF INGUINAL HERNIAS DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY

Author

Toshikazu Takeda, Behfar Ehdaie, Vincent P. Laudone, Ricardo Alvim, Jonathan A. Coleman, and Pedro Recabal

Subjects
medicine.medical_specialty, Mesh repair, Laparoscopic radical prostatectomy, Suture (anatomy), Robotic assisted, business.industry, Urology, medicine.medical_treatment, medicine, business, Surgery
Published
2017
Full Text
View/download PDF

31. MP70-12 PREDICTING EXTENSIVE DISEASE AMONG POTENTIAL CANDIDATES FOR HEMI-ABLATIVE FOCAL THERAPY FOR PROSTATE CANCER

Author

James A. Eastham, Peter T. Scardino, Nicole Benfante, Toshikazu Takeda, Daniel Sjöberg, Nicola L. Robertson, Renato B. Corradi, Samson W. Fine, Hebert Alberto Vargas, Maha Mamoor, Karim Touijer, and Amy Tin

Subjects
Oncology, Focal therapy, medicine.medical_specialty, Prostate cancer, Extensive Disease, business.industry, Urology, Internal medicine, Ablative case, Medicine, business, medicine.disease
Published
2017
Full Text
View/download PDF

32. MP70-05 DEFINING THE INDEX LESION FOR SALVAGE PARTIAL GLAND ABLATION AFTER RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER

Author

Behfar Ehdaie, Hebert Alberto Vargas, Toshikazu Takeda, Samson W. Fine, Arjun Sivaraman, and James A. Eastham

Subjects
Oncology, medicine.medical_specialty, Index Lesion, business.industry, Urology, medicine.medical_treatment, Ablation, medicine.disease, Radiation therapy, Prostate cancer, Internal medicine, medicine, Radiology, business
Published
2017
Full Text
View/download PDF

35. 51 LAPAROSCOPIC ADRENALECTOMY INCLUDING LESS IN PATIENTS WITH PHEOCHROMOCYTOMA: THE EVALUATION OF PERIOPERATIVE SURGICAL RISK

Author

Ken Nakagawa, Akira Miyajima, Seiya Hattori, Takahiro Maeda, Mototsugu Oya, Eiji Kikuchi, and Toshikazu Takeda

Subjects
medicine.medical_specialty, business.industry, Urology, Adrenalectomy, medicine.medical_treatment, Hemodynamics, Postoperative complication, Perioperative, medicine.disease, Surgery, Pheochromocytoma, Blood pressure, Pneumoperitoneum, Anesthesia, Medicine, business, Benign adrenal tumors
Abstract

INTRODUCTION AND OBJECTIVES: Laparoendoscopic single-site adrenalectomy (LESS-A) has been developed as a treatment option for adrenal tumors that has cosmetic benefit and less postoperative pain. Some reports proposed that patient selection criteria should be stringent, and pheochromocytoma (PHE) should be taken as advanced indication. Here, we examined the perioperative outcomes of PHE patients who underwent laparoscopic adrenalectomy (LA), while paying special attention to any differences in surgical techniques. METHODS: The records of a total of 233 consecutive patients who underwent LA at our hospital from May 2001 to February 2012 were entered into a database. Surgical procedures were performed by two experienced laparoscopic surgeons. 1) 50 patients who underwent LA for PHE (group PHE, n 50) were compared with patients who underwent LA for other benign adrenal tumors (group non-PHE, n 183). 2) 20 consecutive patients with PHE who underwent LESS-A were compared with patients with PHE who underwent conventional LA (c-LA, n 30). RESULTS: 1) Each group was equivalent with respect to age, sex, BMI, tumor side, perioperativeiicomplication rate, and intraoperative bleeding. There were significant differences in mean size (nonPHE/PHE: 22.8 14.8 mm/46.0 21.9 mm, p 0.001) and mean pneumoperitoneum time (non-PHE/PHE: 85.3 33.0 mm/123.7 55.1 min, p 0.001) between the two groups. At least one postoperative complication (Clavien-Grade 2) occurred in 13 patients (non-PHE/PHE: 10 cases/3 cases). 2) Each group was statistically equivalent with respect to age, BMI, tumor size, operative time, intraoperative bleeding, and postoperative hospital stay. There were no significant differences in preoperative hemodynamic variables between the two groups. There were no significant differences in the highest intraoperative blood pressure (LESSA/c-LA: 161.7 7.8 mmHg/180.6 7.4 mmHg, p 0.096), hypertensive episodes (LESS-A/c-LA: 10 cases/23 cases, p 0.051), or intraoperative hypotensive episodes (LESS-A/c-LA: 4 cases/9 cases, p 0.557). In one case of LESS-A, two additional ports were added. There were 3 perioperative complications (LESS-A/c-LA: 2 cases/1 case, p 0.331). CONCLUSIONS: LA was safely performed in patients with PHE compared with that of non-PHE patients. We concluded the safety of LESS-A for PHE as being similar to that of LA. With appropriate preand intra-operative hemodynamic control and experienced hands, LESS-A could become one of the treatments of choice for resection of PHE.

Published
2013
Full Text
View/download PDF

37. 1019 THERAPEUTIC EFFECT AFTER TRANSUMBILICAL LAPAROSCOPIC SINGLE-SITE ADRENALECTOMY IN PATIENTS WITH PRIMARY ALDOSTERONISM: A MATCHED CASE-CONTROL STUDY

Author

Masanori Hasegawa, Takeo Kosaka, Toshikazu Takeda, Eiji Kikuchi, Seiya Hattori, Takahiro Maeda, Akira Miyajima, Mototsugu Oya, and Ken Nakagawa

Subjects
medicine.medical_specialty, business.industry, Urology, Adrenalectomy, medicine.medical_treatment, Therapeutic effect, Case-control study, medicine.disease, Primary aldosteronism, Single site, medicine, In patient, business
Published
2012
Full Text
View/download PDF

38. 1356 METASTIN, THE FINAL PEPTIDE OF KISS-1 GENE, PREVENTS LUNG METASTASES OF MURINE BLADDER CANCER

Author

Shuji Mikami, Eiji Kikuchi, Masaru Ishida, Eriko Suzuki, Kazuhiro Matsumoto, Akira Miyajima, Mototsugu Oya, Yujiro Ito, and Toshikazu Takeda

Subjects
Oncology, chemistry.chemical_classification, medicine.medical_specialty, Lung, Bladder cancer, business.industry, Urology, Peptide, medicine.disease, KISS (TNC), medicine.anatomical_structure, chemistry, Internal medicine, Medicine, business, Gene
Published
2011
Full Text
View/download PDF

39. 1741 COULD PATIENT AGE INFLUENCE TUMOR RECURRENCE RATE IN NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH BCG IMMUNOTHERAPY?

Author

Kazuhiro Matsumoto, Akira Miyajima, Nobuyuki Tanaka, Mototsugu Oya, Kazuyuki Yuge, Toshikazu Takeda, Ken Nakagawa, and Eiji Kikuchi

Subjects
Oncology, medicine.medical_specialty, Bladder cancer, business.industry, Urology, Bcg immunotherapy, medicine.disease, Tumor recurrence, Patient age, Internal medicine, medicine, Non muscle invasive, business
Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results